Dihydroxyadenin urolithiasis

Adenine phosphoribosyltransferase deficiency is an autosomal recessive disorder characterized by sedimentation of dihydroxyadenine in the urinary tract (DHA urolithiasis).

Management

For the management of adenine phosphoribosyltransferase deficiency Allopurinol treatment can be recommended. Febuxostat provides an plausible alternative though not yet tested and/or published with that disorder. Additional supportive therapy includes sufficient water intake and early treatment of urogenital infections.

Systematic

Urolithiasis
	Cystinuria
	Dicarboxylic aminoaciduria
	Dihydroxyadenin urolithiasis
		APRT
	Nephrocalcinosis
	Nephrolithiasis diarrhea syndrome
	Susceptibility to nephrolithiasis
	Uric acid nephropathy